Compass Group (CMPGY)
PNK: CMPGY
· Real-Time Price · USD
34.52
-0.15 (-0.43%)
At close: May 12, 2025, 3:59 PM
-0.43% (1D)
| Bid | 34.51 |
| Market Cap | 58.59B |
| Revenue (ttm) | 47.47B |
| Net Income (ttm) | 2B |
| EPS (ttm) | 0.82 |
| PE Ratio (ttm) | 42.1 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 34.54 |
| Volume | 40,300 |
| Avg. Volume (20D) | 273,432 |
| Open | 34.36 |
| Previous Close | 34.67 |
| Day's Range | 34.16 - 34.64 |
| 52-Week Range | 27.39 - 36.33 |
| Beta | 0.58 |
About CMPGY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPGY
Website n/a
23 hours ago · seekingalpha.com
Compass Therapeutics: A Big Positive Signal For Tovecimig In Biliary Tract CancersCompass Therapeutics' tovecimig shows promise in biliary tract cancer with a 17.1% response rate, but further survival data is crucial for potential approval. CMPX's cash runway extends into early 202...
